Russian Journal of Infection and Immunity
ISSN 2220-7619 · Sankt-Peterburg : NIIÈM imeni Pastera · Russian Federation · active 2011–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Russian Journal of Infection and Immunity a predatory journal?
Our screening does not flag Russian Journal of Infection and Immunity. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, which is a positive signal.
Is Russian Journal of Infection and Immunity indexed in Scopus or Web of Science?
Per our venue index, Russian Journal of Infection and Immunity appears in: DOAJ, Scopus, Web of Science. Index membership changes over time — confirm on the index's own site before relying on it.
What is Russian Journal of Infection and Immunity's impact?
Papers in Russian Journal of Infection and Immunity are cited about 0.4 times each within two years of publication, and Scimago places it in Q4, with an h-index of 17. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Russian Journal of Infection and Immunity open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Signal Transduction and Targeted TherapyQ1 · Springer Nature
- MMWR Morbidity and Mortality Weekly ReportQ1 · Centers for Disease Control and Prevention
- Science Translational MedicineQ1 · American Association for the Advancement of Science
- Cell DiscoveryQ1 · Springer Nature
- The Lancet MicrobeQ1 · Elsevier BV
- The Lancet Infectious DiseasesQ1 · Elsevier BV